Common Genetic Variants and Modification of Penetrance of -Associated Breast Cancer

English version České info

The considerable uncertainty regarding cancer risks associated with inherited mutations of BRCA2 is due to unknown factors. To investigate whether common genetic variants modify penetrance for BRCA2 mutation carriers, we undertook a two-staged genome-wide association study in BRCA2 mutation carriers. In stage 1 using the Affymetrix 6.0 platform, 592,163 filtered SNPs genotyped were available on 899 young (<40 years) affected and 804 unaffected carriers of European ancestry. Associations were evaluated using a survival-based score test adjusted for familial correlations and stratified by country of the study and BRCA2*6174delT mutation status. The genomic inflation factor (λ) was 1.011. The stage 1 association analysis revealed multiple variants associated with breast cancer risk: 3 SNPs had p-values<10⁻⁵ and 39 SNPs had p-values<10⁻⁴. These variants included several previously associated with sporadic breast cancer risk and two novel loci on chromosome 20 (rs311499) and chromosome 10 (rs16917302). The chromosome 10 locus was in ZNF365, which contains another variant that has recently been associated with breast cancer in an independent study of unselected cases. In stage 2, the top 85 loci from stage 1 were genotyped in 1,264 cases and 1,222 controls. Hazard ratios (HR) and 95% confidence intervals (CI) for stage 1 and 2 were combined and estimated using a retrospective likelihood approach, stratified by country of residence and the most common mutation, BRCA2*6174delT. The combined per allele HR of the minor allele for the novel loci rs16917302 was 0.75 (95% CI 0.66–0.86, ) and for rs311499 was 0.72 (95% CI 0.61–0.85, ). FGFR2 rs2981575 had the strongest association with breast cancer risk (per allele HR = 1.28, 95% CI 1.18–1.39, ). These results indicate that SNPs that modify BRCA2 penetrance identified by an agnostic approach thus far are limited to variants that also modify risk of sporadic BRCA2 wild-type breast cancer.

Vyšlo v časopise: Common Genetic Variants and Modification of Penetrance of -Associated Breast Cancer. PLoS Genet 6(10): e32767. doi:10.1371/journal.pgen.1001183
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1001183

Souhrn

Zdroje

1. TryggvadottirL

SigvaldasonH

OlafsdottirGH

JonassonJG

JonssonT

2006 Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920–2000. J Natl Cancer Inst 98 116 122

2. SimchoniS

FriedmanE

KaufmanB

Gershoni-BaruchR

Orr-UrtregerA

2006 Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A 103 3770 3774

3. BeggCB

HaileRW

BorgA

MaloneKE

ConcannonP

2008 Variation of breast cancer risk among BRCA1/2 carriers. JAMA 299 194 201

4. AntoniouA

PharoahPD

NarodS

RischHA

EyfjordJE

2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72 1117 1130

5. RobsonM

OffitK

2007 Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 357 154 162

6. OffitK

2006 BRCA mutation frequency and penetrance: new data, old debate. J Natl Cancer Inst 98 1675 1677

7. AntoniouAC

PharoahPD

McMullanG

DayNE

StrattonMR

2002 A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86 76 83

8. AntoniouAC

PharoahPD

McMullanG

DayNE

PonderBA

2001 Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21 1 18

9. AntoniouAC

SinilnikovaOM

SimardJ

LeoneM

DumontM

2007 RAD51 135G→C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 81 1186 1200

10. CatucciI

VerderioP

PizzamiglioS

ManoukianS

PeisselB

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. Breast Cancer Res Treat

11. Palanca SuelaS

Esteban CardenosaE

Barragan GonzalezE

de Juan JimenezI

Chirivella GonzalezI

CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. Breast Cancer Res Treat 119 87 93

12. NeuhausenSL

BrummelS

DingYC

SingerCF

PfeilerG

2009 Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Res 11 R76

13. AntoniouAC

SpurdleAB

SinilnikovaOM

HealeyS

PooleyKA

2008 Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82 937 948

14. SegreAV

GroopL

MoothaVK

DalyMJ

AltshulerD

2010 Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet 6 e1001058 doi:10.1371/journal.pgen.1001058

15. D'AndreaAD

Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med 362 1909 1919

16. O'DonovanPJ

LivingstonDM

2010 BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis 31 961 967

17. StadlerZ

ThomP

RobsonME

WeitzelJN

KauffND

2010 Genome-wide Association Studies of Cancer. J Clin Oncol in press

18. AntoniouAC

2010 A genome-wide association study identified a 19p13 locus that modifies the risk of breast cancer in BRCA1 mutation carriers and is associated with estrogen receptor negative and triple negative breast cancer in the general population. Nat Genet under review

19. KirchhoffT

ChenZQ

GoldB

PalP

GaudetMM

2009 The 6q22.33 Locus and Breast Cancer Susceptibility. Cancer Epidemiol Biomarkers Prev

20. AntoniouAC

SinilnikovaOM

McGuffogL

HealeyS

NevanlinnaH

2009 Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet

21. ZollnerS

PritchardJK

2007 Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am J Hum Genet 80 605 615

22. EllisNA

KirchhoffT

MitraN

YeTZ

ChuaiS

2006 Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping. Genet Epidemiol 30 48 61

23. GusevA

LoweJK

StoffelM

DalyMJ

AltshulerD

2009 Whole population, genome-wide mapping of hidden relatedness. Genome Res 19 318 326

24. TurnbullC

AhmedS

MorrisonJ

PernetD

RenwickA

Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet

25. AntoniouAC

CunninghamAP

PetoJ

EvansDG

LallooF

2008 The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 98 1457 1466

26. FoulkesWD

StefanssonIM

ChappuisPO

BeginLR

GoffinJR

2003 Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95 1482 1485

27. WangX

PankratzVS

FredericksenZ

TarrellR

KarausM

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 19 2886 2897

28. Chenevix-TrenchG

MilneRL

AntoniouAC

CouchFJ

EastonDF

2007 An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 9 104

29. KornJM

KuruvillaFG

McCarrollSA

WysokerA

NemeshJ

2008 Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet 40 1253 1260

30. AntoniouAC

GoldgarDE

AndrieuN

Chang-ClaudeJ

BrohetR

2005 A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 29 1 11

31. ToninP

WeberB

OffitK

CouchF

RebbeckTR

1996 Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2 1179 1183

32. NeuhausenS

GilewskiT

NortonL

TranT

McGuireP

1996 Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13 126 128

33. NeuhausenSL

MazoyerS

FriedmanL

StrattonM

OffitK

1996 Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58 271 280

34. OlshenAB

GoldB

LohmuellerKE

StruewingJP

SatagopanJ

2008 Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping. BMC Genet 9 14

35. AminN

van DuijnCM

AulchenkoYS

2007 A genomic background based method for association analysis in related individuals. PLoS ONE 2 e1274 doi:10.1371/journal.pone.0001274

36. LeuteneggerAL

PrumB

GeninE

VernyC

LemainqueA

2003 Estimation of the inbreeding coefficient through use of genomic data. Am J Hum Genet 73 516 523

37. AulchenkoYS

RipkeS

IsaacsA

van DuijnCM

2007 GenABEL: an R library for genome-wide association analysis. Bioinformatics 23 1294 1296

38. LangeK

WeeksD

BoehnkeM

1988 Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 5 471 472

39. HuberPJ

1967 The behaviour of maximum maximum likelihood estimates under non-standard conditions. Proceedings of the Fifth Berkeley Symposium in Mathematical Statistics and Probability 1 221 233

40. LinDY

WeiLJ

1989 The robust inference for the cox-proportional hazards model. J Am Stat Assoc 84 1074 1078

41. PurcellS

NealeB

Todd-BrownK

ThomasL

FerreiraMA

2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 559 575

42. ChenH

SharpBM

2004 Content-rich biological network constructed by mining PubMed abstracts. BMC Bioinformatics 5 147